BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

551 related articles for article (PubMed ID: 23697546)

  • 1. Forecasting the future of stroke in the United States: a policy statement from the American Heart Association and American Stroke Association.
    Ovbiagele B; Goldstein LB; Higashida RT; Howard VJ; Johnston SC; Khavjou OA; Lackland DT; Lichtman JH; Mohl S; Sacco RL; Saver JL; Trogdon JG;
    Stroke; 2013 Aug; 44(8):2361-75. PubMed ID: 23697546
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Forecasting the future of cardiovascular disease in the United States: a policy statement from the American Heart Association.
    Heidenreich PA; Trogdon JG; Khavjou OA; Butler J; Dracup K; Ezekowitz MD; Finkelstein EA; Hong Y; Johnston SC; Khera A; Lloyd-Jones DM; Nelson SA; Nichol G; Orenstein D; Wilson PW; Woo YJ; ; ; ; ; ; ; ; ; ; ; ; ;
    Circulation; 2011 Mar; 123(8):933-44. PubMed ID: 21262990
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Projected Costs of Informal Caregiving for Cardiovascular Disease: 2015 to 2035: A Policy Statement From the American Heart Association.
    Dunbar SB; Khavjou OA; Bakas T; Hunt G; Kirch RA; Leib AR; Morrison RS; Poehler DC; Roger VL; Whitsel LP;
    Circulation; 2018 May; 137(19):e558-e577. PubMed ID: 29632217
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Forecasting the impact of heart failure in the United States: a policy statement from the American Heart Association.
    Heidenreich PA; Albert NM; Allen LA; Bluemke DA; Butler J; Fonarow GC; Ikonomidis JS; Khavjou O; Konstam MA; Maddox TM; Nichol G; Pham M; Piña IL; Trogdon JG; ; ; ; ; ;
    Circ Heart Fail; 2013 May; 6(3):606-19. PubMed ID: 23616602
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Forecasting the Economic Burden of Cardiovascular Disease and Stroke in the United States Through 2050: A Presidential Advisory From the American Heart Association.
    Kazi DS; Elkind MSV; Deutsch A; Dowd WN; Heidenreich P; Khavjou O; Mark D; Mussolino ME; Ovbiagele B; Patel SS; Poudel R; Weittenhiller B; Powell-Wiley TM; Joynt Maddox KE;
    Circulation; 2024 Jun; ():. PubMed ID: 38832515
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Future costs of stroke in the Netherlands: the impact of stroke services.
    Struijs JN; van Genugten ML; Evers SM; Ament AJ; Baan CA; van den Bos GA
    Int J Technol Assess Health Care; 2006; 22(4):518-24. PubMed ID: 16984687
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inclusion of stroke in cardiovascular risk prediction instruments: a statement for healthcare professionals from the American Heart Association/American Stroke Association.
    Lackland DT; Elkind MS; D'Agostino R; Dhamoon MS; Goff DC; Higashida RT; McClure LA; Mitchell PH; Sacco RL; Sila CA; Smith SC; Tanne D; Tirschwell DL; Touzé E; Wechsler LR; ; ; ; ; ;
    Stroke; 2012 Jul; 43(7):1998-2027. PubMed ID: 22627990
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The future incidence, prevalence and costs of stroke in the UK.
    King D; Wittenberg R; Patel A; Quayyum Z; Berdunov V; Knapp M
    Age Ageing; 2020 Feb; 49(2):277-282. PubMed ID: 31957781
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Economic costs of overactive bladder in the United States.
    Ganz ML; Smalarz AM; Krupski TL; Anger JT; Hu JC; Wittrup-Jensen KU; Pashos CL
    Urology; 2010 Mar; 75(3):526-32, 532.e1-18. PubMed ID: 20035977
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The annual impact of seasonal influenza in the US: measuring disease burden and costs.
    Molinari NA; Ortega-Sanchez IR; Messonnier ML; Thompson WW; Wortley PM; Weintraub E; Bridges CB
    Vaccine; 2007 Jun; 25(27):5086-96. PubMed ID: 17544181
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Stroke outcomes measures must be appropriately risk adjusted to ensure quality care of patients: a presidential advisory from the American Heart Association/American Stroke Association.
    Fonarow GC; Alberts MJ; Broderick JP; Jauch EC; Kleindorfer DO; Saver JL; Solis P; Suter R; Schwamm LH
    Stroke; 2014 May; 45(5):1589-601. PubMed ID: 24523036
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Heart Disease and Stroke Statistics-2020 Update: A Report From the American Heart Association.
    Virani SS; Alonso A; Benjamin EJ; Bittencourt MS; Callaway CW; Carson AP; Chamberlain AM; Chang AR; Cheng S; Delling FN; Djousse L; Elkind MSV; Ferguson JF; Fornage M; Khan SS; Kissela BM; Knutson KL; Kwan TW; Lackland DT; Lewis TT; Lichtman JH; Longenecker CT; Loop MS; Lutsey PL; Martin SS; Matsushita K; Moran AE; Mussolino ME; Perak AM; Rosamond WD; Roth GA; Sampson UKA; Satou GM; Schroeder EB; Shah SH; Shay CM; Spartano NL; Stokes A; Tirschwell DL; VanWagner LB; Tsao CW;
    Circulation; 2020 Mar; 141(9):e139-e596. PubMed ID: 31992061
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Economic burden of coronary heart disease and stroke attributable to hypertension in China].
    Zhai Y; Hu JP; Kong LZ; Zhao WH; Chen CM
    Zhonghua Liu Xing Bing Xue Za Zhi; 2006 Sep; 27(9):744-7. PubMed ID: 17299955
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Recommendations for the management of cerebral and cerebellar infarction with swelling: a statement for healthcare professionals from the American Heart Association/American Stroke Association.
    Wijdicks EF; Sheth KN; Carter BS; Greer DM; Kasner SE; Kimberly WT; Schwab S; Smith EE; Tamargo RJ; Wintermark M;
    Stroke; 2014 Apr; 45(4):1222-38. PubMed ID: 24481970
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Value of primordial and primary prevention for cardiovascular disease: a policy statement from the American Heart Association.
    Weintraub WS; Daniels SR; Burke LE; Franklin BA; Goff DC; Hayman LL; Lloyd-Jones D; Pandey DK; Sanchez EJ; Schram AP; Whitsel LP; ; ; ; ; ; ; ;
    Circulation; 2011 Aug; 124(8):967-90. PubMed ID: 21788592
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Risk adjustment of ischemic stroke outcomes for comparing hospital performance: a statement for healthcare professionals from the American Heart Association/American Stroke Association.
    Katzan IL; Spertus J; Bettger JP; Bravata DM; Reeves MJ; Smith EE; Bushnell C; Higashida RT; Hinchey JA; Holloway RG; Howard G; King RB; Krumholz HM; Lutz BJ; Yeh RW; ; ; ; ; ;
    Stroke; 2014 Mar; 45(3):918-44. PubMed ID: 24457296
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Economic costs of diabetes in the U.S. In 2007.
    American Diabetes Association
    Diabetes Care; 2008 Mar; 31(3):596-615. PubMed ID: 18308683
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The boomers are coming: a total cost of care model of the impact of population aging on the cost of chronic conditions in the United States.
    Garrett N; Martini EM
    Dis Manag; 2007 Apr; 10(2):51-60. PubMed ID: 17444790
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Estimates of the direct and indirect costs of acquired immunodeficiency syndrome in the United States, 1985, 1986, and 1991.
    Scitovsky AA; Rice DP
    J Med Pract Manage; 1988; 3(4):234-41. PubMed ID: 10314299
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Incidence and economic burden of osteoporosis-related fractures in the United States, 2005-2025.
    Burge R; Dawson-Hughes B; Solomon DH; Wong JB; King A; Tosteson A
    J Bone Miner Res; 2007 Mar; 22(3):465-75. PubMed ID: 17144789
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 28.